A Study to Investigate Mocertatug Rezetecan With Bevacizumab Compared With Platinum Doublet With Bevacizumab in Participants With Platinum-sensitive Ovarian Cancer (BEHOLD-Ovarian02)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study specifically aims to evaluate how well mocertatug rezetecan (Mo-Rez) in combination with bevacizumab works in treating platinum-sensitive ovarian cancer compared to standard treatments by checking whether it makes cancers smaller or disappear completely and if it helps participants live longer. The study also assesses whether Mo-Rez in combination with bevacizumab is safe and tolerated well by participants compared to standard treatments and aims to provide a better understanding of the main side effects of Mo-Rez.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Masz ukończone 18 lat i jesteś zdolna do wyrażenia zgody na udział w badaniu.
- •Masz raka jajnika, otrzewnej lub jajowodu.
- •Choroba powróciła lub postępuje po co najmniej jednej i maksymalnie dwóch wcześniejszych terapiach przeciwnowotworowych.
- •Twój rak jest wrażliwy na platynę, co oznacza, że nawrót nastąpił ponad 6 miesięcy po ostatniej chemioterapii z użyciem platyny.
- •Masz wyniki badań genetycznych (BRCA1/BRCA2) dotyczących guza lub komórek rozrodczych.
✗ Disqualifies
- •Wcześniej ukończyłaś terapię podtrzymującą inhibitorami PARP (jeśli masz mutację BRCA).
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 1, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (9)
GSK Investigational Site
Newcastle, Australia
GSK Investigational Site
Toronto, Canada
GSK Investigational Site
Montreal, Canada
GSK Investigational Site
Hokkaido, Japan
GSK Investigational Site
Hyōgo, Japan
GSK Investigational Site
Ibaraki, Japan
GSK Investigational Site
Seoul, South Korea
GSK Investigational Site
Seoul, South Korea
GSK Investigational Site
Seoul, South Korea
Trial contact
US GSK Clinical Trials Call Center
EU GSK Clinical Trials Call Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.